BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37930294)

  • 1. Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review.
    Gao Y; Guo L; Wang F; Wang Y; Li P; Zhang D
    Cytotherapy; 2024 Jan; 26(1):11-24. PubMed ID: 37930294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing.
    Mok BY; de Moraes MH; Zeng J; Bosch DE; Kotrys AV; Raguram A; Hsu F; Radey MC; Peterson SB; Mootha VK; Mougous JD; Liu DR
    Nature; 2020 Jul; 583(7817):631-637. PubMed ID: 32641830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and prospects in mitochondrial genome editing.
    Phan HTL; Lee H; Kim K
    Exp Mol Med; 2023 May; 55(5):871-878. PubMed ID: 37121968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in mitochondrial DNA base editing technology.
    Song RJ; Han L; Sun HF; Shen B
    Yi Chuan; 2023 Aug; 45(8):632-642. PubMed ID: 37609815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
    Lee S; Lee H; Baek G; Namgung E; Park JM; Kim S; Hong S; Kim JS
    Genome Biol; 2022 Oct; 23(1):211. PubMed ID: 36224582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases.
    Lee H; Lee S; Baek G; Kim A; Kang BC; Seo H; Kim JS
    Nat Commun; 2021 Feb; 12(1):1190. PubMed ID: 33608520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors.
    Lee S; Lee H; Baek G; Kim JS
    Nat Biotechnol; 2023 Mar; 41(3):378-386. PubMed ID: 36229610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New potentials of mitochondrial DNA editing.
    Wang W; Wang X
    Cell Biol Toxicol; 2020 Oct; 36(5):391-393. PubMed ID: 32734362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock-In Strategy for Editing Human and Zebrafish Mitochondrial DNA Using Mito-CRISPR/Cas9 System.
    Bian WP; Chen YL; Luo JJ; Wang C; Xie SL; Pei DS
    ACS Synth Biol; 2019 Apr; 8(4):621-632. PubMed ID: 30955321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research progress in mitochondrial gene editing technology.
    Wang Y; Wang Y; Chen Y; Yan Q; Lin A
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):460-472. PubMed ID: 37643980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in methods for reducing mitochondrial DNA disease by replacing or manipulating the mitochondrial genome.
    Rai PK; Craven L; Hoogewijs K; Russell OM; Lightowlers RN
    Essays Biochem; 2018 Jul; 62(3):455-465. PubMed ID: 29950320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases.
    Cho SI; Lee S; Mok YG; Lim K; Lee J; Lee JM; Chung E; Kim JS
    Cell; 2022 May; 185(10):1764-1776.e12. PubMed ID: 35472302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial genome editing: strategies, challenges, and applications.
    Lim K
    BMB Rep; 2024 Jan; 57(1):19-29. PubMed ID: 38178652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of mitochondrial genome engineering.
    Silva-Pinheiro P; Minczuk M
    Nat Rev Genet; 2022 Apr; 23(4):199-214. PubMed ID: 34857922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue.
    Silva-Pinheiro P; Nash PA; Van Haute L; Mutti CD; Turner K; Minczuk M
    Nat Commun; 2022 Feb; 13(1):750. PubMed ID: 35136065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base editing of organellar DNA with programmable deaminases.
    Kim JS; Chen J
    Nat Rev Mol Cell Biol; 2024 Jan; 25(1):34-45. PubMed ID: 37794167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases.
    Lu Y; Happi Mbakam C; Song B; Bendavid E; Tremblay JP
    Front Genome Ed; 2022; 4():892769. PubMed ID: 35958050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies towards therapeutic manipulation of mtDNA heteroplasmy.
    Pereira CV; Moraes CT
    Front Biosci (Landmark Ed); 2017 Jan; 22(6):991-1010. PubMed ID: 27814659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial diseases and mtDNA editing.
    Song M; Ye L; Yan Y; Li X; Han X; Hu S; Yu M
    Genes Dis; 2024 May; 11(3):101057. PubMed ID: 38292200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools for editing the mammalian mitochondrial genome.
    Moraes CT
    Hum Mol Genet; 2024 May; 33(R1):R92-R99. PubMed ID: 38779768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.